Home Français Menu

Menu

shopping cart icon

Job Board > Principal Scientist - VIDO

Principal Scientist - VIDO

Province: Saskatoon, Saskatchewan
Position: Principal Scientist
Deadline: February 28, 2022
VIDO_Logo%2b-%2bFull-Color-RGB.jpg

Job Description / Duties

The Vaccine and Infectious Disease Organization (VIDO) is becoming Canada’s Centre for Pandemic Research. Located at the University of Saskatchewan in Saskatoon, Canada, VIDO is a leader in human and animal infectious disease research and vaccine development. VIDO is home to one of the largest and most advanced level 3 containment facilities capable of housing both small and large animals including rodents, poultry, pigs, cattle, and bison. We are currently expanding our infrastructure to include a vaccine GMP manufacturing facility, an animal facility for exotic species, and upgrade to level 4 containment. Our vision includes the capacity to study any emerging disease in any animal model embracing a One Health approach to prevent emerging and re-emerging infectious diseases in humans and animals.

Additional Information



Review of applications will begin immediately; however, applications will be accepted and evaluated until the position is fille. We thank all applicants for their interest; only those candidates selected for an interview will be contacted.
For more information visit: vido.org

Contact Information

Interested candidates are asked to submit their application including a statement of research interest, cover letter, CV, and the names of three references online via the following link: https://vido.humi.ca/job-board/research/6558

Employer Profile

The Vaccine and Infectious Disease Organization (VIDO) is becoming Canada’s Centre for Pandemic Research. Located at the University of Saskatchewan in Saskatoon, Canada, VIDO is a leader in human and animal infectious disease research and vaccine development. VIDO is home to one of the largest and most advanced level 3 containment facilities capable of housing both small and large animals including rodents, poultry, pigs, cattle, and bison. We are currently expanding our infrastructure to include a vaccine GMP manufacturing facility, an animal facility for exotic species, and upgrade to level 4 containment. Our vision includes the capacity to study any emerging disease in any animal model embracing a One Health approach to prevent emerging and re-emerging infectious diseases in humans and animals.